{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T22:32:35Z","timestamp":1769380355318,"version":"3.49.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.leukres.2008.09.024","type":"journal-article","created":{"date-parts":[[2008,11,4]],"date-time":"2008-11-04T22:01:23Z","timestamp":1225836083000},"page":"710-716","source":"Crossref","is-referenced-by-count":33,"title":["Imatinib resistance in multidrug-resistant K562 human leukemic cells"],"prefix":"10.1016","volume":"33","author":[{"given":"Yanina","family":"Assef","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgina","family":"Col\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvana","family":"del M\u00f3naco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica A.","family":"Costas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basilio A.","family":"Kotsias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2008.09.024_bib1","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1152\/physrev.1997.77.2.545","article-title":"Kinetics of the multidrug transporter (P-glycoprotein) and its reversal","volume":"77","author":"Stein","year":"1997","journal-title":"Physiol Rev"},{"key":"10.1016\/j.leukres.2008.09.024_bib2","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1042\/bj20020957","article-title":"Structure and function of efflux pumps that confer resistance to drugs","volume":"376","author":"Borges-Walmsley","year":"2003","journal-title":"Biochem J"},{"key":"10.1016\/j.leukres.2008.09.024_bib3","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00232-005-0792-1","article-title":"Recent progress in understanding the mechanism of P-glycoprotein-mediated drug efflux","volume":"206","author":"Loo","year":"2005","journal-title":"J Membr Biol"},{"key":"10.1016\/j.leukres.2008.09.024_bib4","first-page":"383","article-title":"Semiquantitative RT-PCR evaluation of the MDR1 gene expression in patients with acute myeloid leukaemia","volume":"54","author":"Trnkov\u00e1","year":"2007","journal-title":"Neoplasma"},{"key":"10.1016\/j.leukres.2008.09.024_bib5","first-page":"2323","article-title":"Inducible chemoresistance to 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothecin (CPT-11) in colorectal cancer cells and a xenograft model is overcome by inhibition of nuclear factor-kappaB activation","volume":"60","author":"Cusack","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2008.09.024_bib6","doi-asserted-by":"crossref","first-page":"6048","DOI":"10.1038\/sj.onc.1204732","article-title":"Increased and correlated nuclear factor-kappa B and Ku autoantigen activities are associated with development of multidrug resistance","volume":"20","author":"Um","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2008.09.024_bib7","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.onc.1205117","article-title":"Induction of human MDR1 gene expression by 2-acetylaminofluorene is mediated by effectors of the phosphoinositide 3-kinase pathway that activate NF-kB signalling","volume":"21","author":"Kuo","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2008.09.024_bib8","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/sj.onc.1206056","article-title":"NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells","volume":"22","author":"Bentires-Alj","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2008.09.024_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1172\/JCI11891","article-title":"Series introduction: the transcription factor NF-kappaB and human disease","volume":"107","author":"Baldwin","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.leukres.2008.09.024_bib10","doi-asserted-by":"crossref","first-page":"21096","DOI":"10.1074\/jbc.272.34.21096","article-title":"Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo","volume":"272","author":"Pierce","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.leukres.2008.09.024_bib11","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.1128\/MCB.25.13.5429-5444.2005","article-title":"Blockade of histone deacetylase inhibitor-induced RelA\/p65 acetylation and NF-kappaB activation potentiates apoptosis in leukemia cells through a process mediated by oxidative damage, XIAP downregulation, and c-Jun N-terminal kinase 1 activation","volume":"25","author":"Dai","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.leukres.2008.09.024_bib12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0092-8674(00)81318-5","article-title":"NF-\u03baB: ten years after","volume":"87","author":"Bauerle","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2008.09.024_bib13","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/S0092-8674(02)00703-1","article-title":"Missing pieces in the NF-kappaB puzzle","volume":"109","author":"Ghosh","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2008.09.024_bib14","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature04870","article-title":"Nuclear factor-kB in cancer development and progression","volume":"44","author":"Karin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2008.09.024_bib15","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/sj.leu.2401705","article-title":"Transcription factor NF-kappaB is constitutively activated in acute lymphoblastic leukemia cells","volume":"14","author":"Kordes","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2008.09.024_bib16","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1182\/blood.V98.8.2301","article-title":"Nuclear factor-\u03baB is constitutively activated in primitive human acute myelogenous leukemia cells","volume":"98","author":"Guzman","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.09.024_bib17","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1158\/1078-0432.CCR-04-1936","article-title":"Growth inhibition of multiple myeloma cells by a novel IKB kinase inhibitor","volume":"11","author":"Sanda","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.leukres.2008.09.024_bib18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1182\/blood.V45.3.321.321","article-title":"Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome","volume":"45","author":"Lozzio","year":"1977","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.09.024_bib19","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","article-title":"Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells","volume":"2","author":"Druker","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.leukres.2008.09.024_bib20","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1182\/blood-2004-08-3097","article-title":"The development of imatinib as a therapeutic agent for chronic myeloid leukemia","volume":"105","author":"Deininger","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.09.024_bib21","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1182\/blood.V96.3.1070","article-title":"Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: diverse mechanisms of resistance","volume":"96","author":"Mahon","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.09.024_bib22","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1182\/blood.V95.5.1758.005a41_1758_1766","article-title":"Induction of resistance to the Abelson inhibitor STI571 in human leukemic cells through gene amplification","volume":"95","author":"le Coutre","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.09.024_bib23","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1182\/blood.V101.6.2368","article-title":"MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models","volume":"101","author":"Mahon","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.09.024_bib24","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.leukres.2005.02.007","article-title":"Ionic currents in multidrug resistant K562 human leukemic cells","volume":"29","author":"Assef","year":"2005","journal-title":"Leukemia Res"},{"key":"10.1016\/j.leukres.2008.09.024_bib25","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/sj.onc.1209176","article-title":"TNF-alpha enhances estrogen-induced cell proliferation of estrogen-dependent breast tumor cells through a complex containing nuclear factor-kappaB","volume":"25","author":"Rubio","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2008.09.024_bib26","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/sj.leu.2401392","article-title":"Growth inhibition, cytokinesis failure and apoptosis of multidrug-resistant leukemia cells after treatment with P-glycoprotein inhibitory agents","volume":"13","author":"Lehne","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2008.09.024_bib27","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0145-2126(99)00177-0","article-title":"Effect of PSC 833 on the cytotoxicity and pharmacodynamics of mitoxantrone in multidrug-resistant K562 cells","volume":"24","author":"Fukushima","year":"2000","journal-title":"Leukemia Res"},{"key":"10.1016\/j.leukres.2008.09.024_bib28","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/sj.onc.1209897","article-title":"Pharmacological inhibitors of NF-kappaB accelerate apoptosis in chronic lymphocytic leukaemia cells","volume":"26","author":"Pickering","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2008.09.024_bib29","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1349-7006.2003.tb01482.x","article-title":"Reversal of the resistance to STI571 in human chronic myelogenous leukemia K562 cells","volume":"94","author":"Mukai","year":"2003","journal-title":"Cancer Sci"},{"key":"10.1016\/j.leukres.2008.09.024_bib30","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa062867","article-title":"Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia","volume":"355","author":"Druker","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2008.09.024_bib31","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1182\/blood-2003-12-4276","article-title":"Active transport of imatinib into and out of cells: implications for drug resistance","volume":"104","author":"Thomas","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.09.024_bib32","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/sj.leu.2403257","article-title":"P-glycoprotein-mediated drug efflux is a resistance mechanism of chronic myelogenous leukemia cells to treatment with imatinib mesylate","volume":"18","author":"Illmer","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2008.09.024_bib33","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1038\/sj.leu.2404671","article-title":"Resistance reversal by RNAi silencing of MDR1 in CML cells associated with increase in imatinib intracellular levels","volume":"21","author":"Widmer","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2008.09.024_bib34","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.exphem.2005.03.014","article-title":"RNAi-mediated knockdown of P-glycoprotein using a transposon-based vector system durably restores imatinib sensitivity in imatinib-resistant CML cell lines","volume":"33","author":"Rumpold","year":"2005","journal-title":"Exp Hematol"},{"key":"10.1016\/j.leukres.2008.09.024_bib35","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1182\/blood-2003-01-0083","article-title":"Overexpression of P-glycoprotein in K562 cells does not confer resistance to the growth inhibitory effects of imatinib (STI571) in vitro","volume":"102","author":"Ferrao","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.09.024_bib36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cancergencyto.2005.01.015","article-title":"Quantitative molecular monitoring of BCR-ABL and MDR1 transcripts in patients with chronic myeloid leukemia during Imatinib treatment","volume":"162","author":"Galimberti","year":"2005","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.leukres.2008.09.024_bib37","doi-asserted-by":"crossref","first-page":"747","DOI":"10.4161\/cbt.4.7.1826","article-title":"Chronic imatinib mesylate exposure leads to reduced intracellular drug accumulation by induction of the ABCG2 (BCRP) and ABCB1 (MDR1) drug transport pumps","volume":"4","author":"Burger","year":"2005","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.leukres.2008.09.024_bib38","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s11095-007-9376-3","article-title":"Constitutive overexpression of P-glycoprotein, rather than breast cancer resistance protein or organic cation transporter 1, contributes to acquisition of imatinib-resistance in K562 cells","volume":"25","author":"Hirayama","year":"2008","journal-title":"Pharm Res"},{"key":"10.1016\/j.leukres.2008.09.024_bib39","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1023\/A:1026413111733","article-title":"Cellular resistance to vincristine suppresses NF-kappa B activation and apoptosis but enhances c-Jun-NH2-terminal protein kinase activation by tumor necrosis","volume":"4","author":"Giri","year":"1999","journal-title":"Apoptosis"},{"key":"10.1016\/j.leukres.2008.09.024_bib40","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1046\/j.1365-2141.2000.01903.x","article-title":"Constitutive levels of cAMP-dependent protein kinase activity determine sensitivity of human multidrug-resistant leukaemic cell lines to growth inhibition and apoptosis by forskolin and tumour necrosis factor alpha","volume":"108","author":"Yin","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2008.09.024_bib41","first-page":"799","article-title":"NF-kappaB activation contributes to anthracycline resistance pathway in human ovarian carcinoma cell line A2780","volume":"27","author":"Salvatore","year":"2005","journal-title":"Int J Oncol"},{"key":"10.1016\/j.leukres.2008.09.024_bib42","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.leukres.2005.05.004","article-title":"Inhibition of NF-kappaB activity by BAY 11-7082 increases apoptosis in multidrug resistant leukemic T-cell lines","volume":"29","author":"Garc\u00eda","year":"2005","journal-title":"Leukemia Res"},{"key":"10.1016\/j.leukres.2008.09.024_bib43","doi-asserted-by":"crossref","first-page":"14914","DOI":"10.1074\/jbc.272.23.14914","article-title":"Activation of NF-kappaB by antineoplastic agents. Role of protein kinase C","volume":"272","author":"Das","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.leukres.2008.09.024_bib44","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1126\/science.274.5288.782","article-title":"An essential role for NF-\u03baB in preventing TNF-\u03b1-induced cell death","volume":"274","author":"Beg","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.leukres.2008.09.024_bib45","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.1182\/blood.V91.12.4624","article-title":"Inhibition of nuclear factor \u03baB activation attenuates apoptosis resistance in lymphoid cells","volume":"91","author":"Jeremias","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.09.024_bib46","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/sj.cdd.4401877","article-title":"NF-kappaB and IKK as therapeutic targets in cancer","volume":"13","author":"Kim","year":"2006","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.leukres.2008.09.024_bib47","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0014-5793(00)02223-7","article-title":"RAC-3 is a NF-\u03baB coactivator","volume":"485","author":"Werbajh","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1016\/j.leukres.2008.09.024_bib48","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.1016\/j.febslet.2007.09.052","article-title":"RAC3 down-regulation sensitizes human chronic myeloid leukemia cells to TRAIL-induced apoptosis","volume":"581","author":"Colo","year":"2007","journal-title":"FEBS Lett"},{"key":"10.1016\/j.leukres.2008.09.024_bib49","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1021\/bi982236+","article-title":"Negative regulation of MDR1 promoter activity in MCF-7, but not in multidrug resistant MCF-7\/Adr, cells by cross-coupled NF-kB\/p65 and c-Fos transcription factors and their interaction with the CAAT region","volume":"38","author":"Ogretmen","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.leukres.2008.09.024_bib50","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/(SICI)1097-4652(200007)184:1<17::AID-JCP2>3.0.CO;2-U","article-title":"Cell-cycle-dependent turnover of P-glycoprotein in multidrug-resistant cells","volume":"184","author":"Zhang","year":"2000","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.leukres.2008.09.024_bib51","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/jcp.1041630314","article-title":"P-glycoprotein stability is affected by serum deprivation and high cell density in multidrug-resistant cells","volume":"163","author":"Muller","year":"1995","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.leukres.2008.09.024_bib52","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/sj.leu.2403998","article-title":"The NF-kappaB pathway blockade by the IKK inhibitor PS1145 can overcome imatinib resistance","volume":"20","author":"Cilloni","year":"2006","journal-title":"Leukemia"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212608004281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212608004281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T21:47:05Z","timestamp":1589060825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212608004281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0145212608004281"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2008.09.024","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}